Cutaneous T cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
'''For patient information, click [[Cutaneous T cell lymphoma (patient information)|here]]''' | '''For patient information, click [[Cutaneous T cell lymphoma (patient information)|here]]''' | ||
{{Cutaneous T cell lymphoma}} | {{Cutaneous T cell lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{S.G.}} | ||
{{SK}} CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides | {{SK}} CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides | ||
Revision as of 21:10, 11 December 2018
For patient information, click here
|
Cutaneous T cell lymphoma Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Synonyms and keywords: CTCL; Mycosis fungoides; Sezary syndrome; Sezary's disease; Alibert-Bazin syndrome; Granuloma fungoides
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cutaneous T cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Biopsy | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies